To save taxpayer dollars, Congress should look at revamping the USF program instead of trying to expanding its contribution base.
The Case for 340B Reform Is Made on Capitol Hill
At a Capitol Hill briefing on the urgent need for reforms to the 340B Drug Pricing Program, the case was made for prompt action to fix the program. The event took place at the Senate Visitors Center on September 23, 2024, and was hosted by the Council for Citizens Against Government Waste (CCAGW). The panel […]
Protecting Intellectual Property in an AI World
Intellectual property rights should be protected when artificial intelligence is used in creative works.
USPTO-FDA Study Debunks Critics and Demonstrates the Importance of Protecting IP
USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.
The IRA Has Undermined Medicare Part D
The Inflation Reduction Act creates instability in the Medicare Part D Program.
Not-So-Happy Birthday to the Inflation Reduction Act
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
Court Further Delays Net Neutrality Implementation
On August 1, 2024, the U.S. Court of Appeals for the Sixth Circuit extended the stay on the FCC’s latest net neutrality order.
Fifth Circuit Determines the USF Fee Is a Tax
The Fifth Circuit Court rocked the telecommunications world when it released its ruling on funding the USF.
House Defense Bills Break with Pentagon Guidance
Putting the customer at the core of your product development ensures relevance and resonance.
The FTC Wrongly Blames PBMs for High Drug Prices
Putting the customer at the core of your product development ensures relevance and resonance.